Analytical Data
-
Gene name
CEACAM5
- Application
-
Alternative Names
Carcinoembryonic antigen （CEA） （Meconium antigen 100） （CD66e）
-
Species
Human
-
Source
Yeast
-
Tag
N- His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P06731
-
Expression Region
35-685aa(E398K)
-
Molecular Weight
73.3 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
CEACAM5, also known as carcinoembryonic antigen (CEA), is a cell adhesion molecule that plays a significant role in various biological processes, including cell differentiation, proliferation, and immune responses. It is highly expressed in certain epithelial tissues and has been implicated in the pathogenesis of several cancers, particularly colorectal cancer. The study of CEACAM5 recombinant proteins has gained substantial interest due to their potential applications in cancer diagnostics and therapeutics. By expressing CEACAM5 as a recombinant protein, researchers can investigate its structural and functional properties, develop specific antibodies for detection, and explore its role in tumor immune evasion. Additionally, recombinant CEACAM5 can be used as a target for vaccine development or as a diagnostic biomarker, enhancing the specificity and sensitivity of cancer detection. Overall, the research into CEACAM5 recombinant proteins not only deepens our understanding of cancer biology but also opens new avenues for clinical applications in cancer therapy and management.
